Clinical Trials Browser

Phase 1 × Melanoma × Lomustine × Clear all

NCT00527657 2018-11-14

Temozolomide, Thalidomide, and Lomustine (TTL) in Melanoma Patients

Phase 1 Completed

CNSDermatologic

Brain Neoplasms, Melanoma